Cell No. : Cell Name
RCB0621 : SF8428
update : 2022/03/18
|
| Comment | Atomic bomb survivor with breast cancer, different specimen from RCB0624 |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Ban, Sadayuki
|
| Originator |
Ban, Sadayuki
|
| Year of deposit |
1991
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
Japanese
|
| Gender |
Female
|
| Age at sampling |
52 years
|
| Tissue |
skin
|
| Disease name |
atomic bomb survivor
|
| Classification |
normal
|
| Year of origin |
1984
|
|
Lifespan |
finite
|
| Morphology |
fibroblast-like
|
| Cellosaurus(Expasy) |
CVCL_K071
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
MEM ALPHA + 15% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 4 split
|
| SC frequency |
|
Subculture : once/week, Medium Renewal : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| Virus (HIV) |
|
(-)
|
| Isozyme |
|
LD, NP
|
| Chromosome mode |
|
46(50)
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
2
|
| User's Publication |
3
|
| Reference |
|
1449
Ban S, Setlow RB, Ezaki H, Hiraoka T, Yamane M, Nishiki M, Dohi K.
X-ray sensitivity of fibroblast cell strains derived from atomic bomb survivors with and without breast cancer.
J Radiat Res
1991
Suppl:330-8
PubMed ID: 1762123
DOI: 10.1269/jrr.32.supplement_330
|
|
1442
Ban S, Setlow RB, Bender MA, Ezaki H, Hiraoka T, Yamane M, Nishiki M, Dohi K, Awa AA, Miller RC, et al.
Radiosensitivity of skin fibroblasts from atomic bomb survivors with and without breast cancer.
Cancer Res
1990
50(13):4050-5
PubMed ID: 2354455
|
| User's Publication |
|
20743
Sanada A, Yamada T, Hasegawa S, Ishii Y, Hasebe Y, Iwata Y, Arima M, Sugiura K, Akamatsu H.
Enhanced Type I Collagen Synthesis in Fibroblasts by Dermal Stem/Progenitor Cell-Derived Exosomes.
Biol Pharm Bull
2022
45(7):872-880
PubMed ID: 35786595
DOI: 10.1248/bpb.b21-01084
|
|
20841
Miyachi K, Yamada T, Sanada A, Inoue Y, Hasebe Y, Arima M, Iwata Y, Hasegawa S, Sugiura K, Akamatsu H.
Melanin accumulation in dermal stem cells deteriorates their exosome-mediated skin basement membrane construction in solar lentigo.
Exp Dermatol
2022
PubMed ID: 36048560
DOI: 10.1111/exd.14667
|
|
3579
Sudo K, Kanno M, Miharada K, Ogawa S, Hiroyama T, Saijo K, Nakamura Y.
Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations.
Stem Cells
2007
25(7):1610-7
PubMed ID: 17395773
DOI: 10.1634/stemcells.2006-0504
|
Back
Top
CELL BANK Website